4//SEC Filing
PERRY MICHAEL S 4
Accession 0001209191-22-013222
CIK 0001762303other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:54 PM ET
Size
12.7 KB
Accession
0001209191-22-013222
Insider Transaction Report
Form 4
PERRY MICHAEL S
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2022-02-24$8.74/sh−10,812$94,497→ 321,712 total - Award
Common Stock
2022-02-23+23,753→ 326,564 total - Award
Stock Options (Right to Buy)
2022-02-23+3,450→ 3,450 totalExercise: $12.18From: 2022-02-23Exp: 2031-12-22→ Common Stock (3,450 underlying) - Award
Common Stock
2022-02-23+5,960→ 332,524 total
Footnotes (7)
- [F1]These shares of Common Stock were issued upon the vesting of Restricted Stock Units ("RSUs"), which were originally granted on November 26, 2019, in connection with the satisfaction of a performance-based vesting condition.
- [F2]Includes unvested RSUs with vesting conditions based on the Reporting Person's continued employment or the market price of the Issuer's common stock.
- [F3]Includes 634,602 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above.
- [F4]These shares of Common Stock were issued upon the vesting of RSUs, which were originally granted on December 22, 2021, in connection with the satisfaction of a performance-based vesting condition.
- [F5]Represents shares sold in order to pay withholding taxes due in connection with the vesting of RSUs.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.42 to $8.96. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F7]These Stock Options were originally granted on December 22, 2021 and vested on February 23, 2022 in connection with the satisfaction of a performance-based vesting condition.
Documents
Issuer
AVITA Medical, Inc.
CIK 0001762303
Entity typeother
Related Parties
1- filerCIK 0001250379
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 4:54 PM ET
- Size
- 12.7 KB